Filing Details
- Accession Number:
- 0000950170-25-024211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-20 16:30:19
- Reporting Period:
- 2025-02-20
- Filing Date:
- 2025-02-20
- Accepted Time:
- 2025-02-20 16:30:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1762303 | Avita Medical Inc. | RCEL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1387652 | Robert Mcnamara | C/O Avita Medical 28159 Avenue Stanford Suite 220 Valencia CA 91355 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-20 | 10,000 | $10.09 | 45,749 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $10.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares of Common Stock purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- Includes unvested RSUs
Billionaire Hedge Funds
